Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3626
Alpha and Omega Semiconductor
AOSL
$935M
| $346K | ﹤0.01% |
12,587
+8,699
| +224% | +$261K |
2013 Q4
51 quarters
|
|
3627
Sigma Lithium
SGML
$582M
| $346K | ﹤0.01% |
36,819
-816
| -2% | -$8.9K |
2022 Q3
16 quarters
|
|
3628
Climb Bio
CLYM
$717M
| $345K | ﹤0.01% |
30,122
+3,198
| +12% | +$44.6K |
2024 Q2
9 quarters
|
|
3629
Core Laboratories
CLB
$412M
| $345K | ﹤0.01% |
35,540
+12,400
| +54% | +$144K |
2013 Q4
51 quarters
|
|
3630
Babcock & Wilcox
BW
$737M
| $345K | ﹤0.01% |
59,018
+18,258
| +45% | +$160K |
2022 Q1
18 quarters
|
|
3631
Oculis Holding
OCS
$427M
| $344K | ﹤0.01% |
36,881
+33,644
| +1,039% | +$401K |
2026 Q2
1 quarter
|
|
3632
Evolv Technologies
EVLV
$813M
| $343K | ﹤0.01% |
73,834
+43,583
| +144% | +$237K |
2022 Q1
18 quarters
|
|
3633
Tectonic Therapeutic
TECX
$427M
| $343K | ﹤0.01% |
14,731
+5,603
| +61% | +$176K |
2018 Q2
33 quarters
|
|
3634
Klarna Group
KLAR
$5.13B
| $343K | ﹤0.01% |
27,686
-1,946
| -7% | -$32.5K |
2025 Q3
4 quarters
|
|
3635
Applied Aerospace & Defense Inc
AADX
$1.6B
| $343K | ﹤0.01% |
+28,472
| New | +$470K |
2026 Q3
0 quarters
|
|
3636
SunCoke Energy
SXC
$910M
| $342K | ﹤0.01% |
36,288
-49,304
| -58% | -$457K |
2016 Q1
42 quarters
|
|
3637
Arteris
AIP
$1.01B
| $342K | ﹤0.01% |
14,474
+7,106
| +96% | +$194K |
2023 Q3
12 quarters
|
|
3638
Monte Rosa Therapeutics
GLUE
$878M
| $341K | ﹤0.01% |
28,575
-5,892
| -17% | -$101K |
2022 Q1
18 quarters
|
|
3639
Gray Television
GTN
$606M
| $341K | ﹤0.01% |
75,686
+21,940
| +41% | +$98.7K |
2013 Q2
53 quarters
|
|
3640
TWFG Inc
TWFG
$347M
| $341K | ﹤0.01% |
14,184
+3,621
| +34% | +$97.9K |
2025 Q4
3 quarters
|
|
3641
Wabash National
WNC
$487M
| $341K | ﹤0.01% |
27,617
+12,228
| +79% | +$156K |
2013 Q2
53 quarters
|
|
3642
iShares Global Consumer Staples ETF
KXI
$1.18B
| $340K | ﹤0.01% |
5,200
| – | – |
2020 Q4
23 quarters
|
|
3643
Riskified
RSKD
$1.36B
| $339K | ﹤0.01% |
+42,879
| New | +$253K |
2026 Q3
0 quarters
|
|
3644
Hagerty
HGTY
$1.98B
| $339K | ﹤0.01% |
25,181
-433
| -2% | -$5.56K |
2023 Q1
14 quarters
|
|
3645
Grid Dynamics Holdings
GDYN
$1.11B
| $338K | ﹤0.01% |
42,940
+14,498
| +51% | +$104K |
2022 Q1
18 quarters
|
|
3646
Sight Sciences
SGHT
$597M
| $337K | ﹤0.01% |
35,990
+9,408
| +35% | +$66.9K |
2022 Q1
18 quarters
|
|
3647
ING
ING
$95.2B
| $337K | ﹤0.01% |
9,481
-191,311
| -95% | -$6.67M |
2026 Q1
2 quarters
|
|
3648
Zevra Therapeutics
ZVRA
$705M
| $335K | ﹤0.01% |
30,538
-6,355
| -17% | -$75.3K |
2022 Q3
16 quarters
|
|
3649
Universal Logistics Holdings
ULH
$795M
| $335K | ﹤0.01% |
19,373
+18,188
| +1,535% | +$313K |
2019 Q1
30 quarters
|
|
3650
Compass Diversified
CODI
$915M
| $335K | ﹤0.01% |
30,694
+20,648
| +206% | +$227K |
2022 Q1
18 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.